Abstract:e24185 Background: p53, the most commonly mutated gene in human gastric cancer (GC), acts as an important transcriptional regulator, regulates the cell cycle checkpoint and apoptosis signalling pathways. Its functional status was found to be a vital signature for GC molecular subtyping. MicroRNAs can target p53 directly or other factors in the p53 network, regulating the expression and function of wild-type (or the mutant) p53. Therefore, depending on the wild-type or mutant p53 context, the microRNAs’ changing profile may reflect the suppression or promotion of tumor development and even the tumor response to chemotherapy. Since molecular diagnosis has a great impact on precision medicine decisions, to define the function of p53 is of great importance in GC. Methods: We employed miRNA expression data from TCGA and GEO databases to search for candidate miRNAs which correlate with GC patients’ prognosis and treatment outcomes. qPCR was further carried out in two independent cohorts, one with neoadjuvant chemotherapy and one without, for chemotherapy response and prognosis analysis, respectively. Gene set enrichment analysis (GSEA) was conducted to explore the mechanism. GC cell lines AGS and NUGC4 (p53 wild-type), HGC27, MKN45, cells (p53 mutant-type) were assayed for proliferation, migration and cell viability determination with 5-FU treatment. Results: We identified that GC patients with higher miR-140-5p expression had a better overall survival and disease free survival in intestinal type GC, while an adverse trend in patients with diffuse type GC. GSEA indicated lower miR-140-5p correlated with higher expression of cell-cell adherens junction associated genes. However, upregulation of miR-140-5p in cancer cells with activated p53 increased IC50 of 5-FU. We also confirmed that MDM2 and RBBP6, both of which promote p53 degradation, are targets of miR-140-5p, and may contribute to the cell cycle arrest with drug treatment. Conclusions: These findings suggest that miR-140-5p mediates and reflects the function of p53, and thus may influence the progression and the response of chemotherapy in GC.

MiR-155-5p-mediated increase in p53 content induced by dacarbazine in melanoma cells

MiR-204-5p overexpression abrogates Dacarbazine-induced senescence in melanoma cells in vivo MiR-204-5p abrogates senescence

INCREASED LEVEL OF MIR-204-5P EXPRESSION IN MELANOMA CELLS UNDER THE INFLUENCE OF DACARBAZINE

Dnmt1 Mediates Chemosensitivity By Reducing Methylation Of Mirna-20a Promoter In Glioma Cells

Prevention of BMS-777607-induced Polyploidy/senescence by Mtor Inhibitor AZD8055 Sensitizes Breast Cancer Cells to Cytotoxic Chemotherapeutics.

Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway

Deoxyarbutin targets mitochondria to trigger p53-dependent senescence of glioblastoma cells

KDM4B Histone Demethylase Inhibition Attenuates Tumorigenicity of Malignant Melanoma Cells by Overriding the p53‐Mediated Tumor Suppressor Pathway

Berberine-photodynamic induced apoptosis by activating endoplasmic reticulum stress-autophagy pathway involving CHOP in human malignant melanoma cells

Marizomib Promotes Senescence or Long-Term Apoptosis in Melanoma Cancer Cells

Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer

Mitomycin C and its analog trigger cytotoxicity in MCF-7 and K562 cancer cells through the regulation of RAS and MAPK/ERK pathways

Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway

The lack of functional DNMT2/TRDMT1 gene modulates cancer cell responses during drug-induced senescence

Relationship of Mir-140-5p Expression and P53 Function and Contribution to Prognosis Prediction and Treatment Decision of Patients with Gastric Cancer.

p53-Induced Autophagy Regulates Chemotherapy and Radiotherapy Resistance in Multidrug Resistance Cancer Cells

Inhibitory Effect of Bcl-2 on P53-Mediated Transactivation Following Genotoxic Stress

Low Doses of Niclosamide and Quinacrine Combination Yields Synergistic Effect in Melanoma Via Activating Autophagy-Mediated P53-Dependent Apoptosis.

Effect of A Small-Molecule Mdm2/Mdmx Inhibitor on Cell Cycle Arrest and Apoptosis in Breast Cancer Cells.

Microrna-149*, A P53-Responsive Microrna, Functions As An Oncogenic Regulator In Human Melanoma

p53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer